ArticleChina CDC weekly2022
Malaria Elimination in China and Sustainability Concerns in the Post-elimination Stage.
Article in China CDC weekly, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed, 6 citations in OpenAlex.
- Immunodominant B-cell epitopes for precision surveillance ofEmerging microbes & infections · 2026Article
- Article
- Event-driven dynamics, regional disparities, and netizen engagement: characterizing and exploring malaria discourse on Sina Weibo for enhanced health communication.Malaria journal · 2025Article
- Drug Resistance of ImportedChina CDC weekly · 2025Article
- Application of Remote Sensing Methods in Predicting the Dynamics ofChina CDC weekly · 2025Article
- Lessons from failure to success on malaria elimination in the Huai River Basin in China.BMJ (Clinical research ed.) · 2025Article
- Risk assessment of imported malaria in China: a machine learning perspective.BMC public health · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The World Health Organization (WHO) certified China as officially malaria-free on June 30, 2021. Looking back at the public health history in China, malaria elimination has been a product of complex social engineering. Here, we summarized our experience and lessons, and found that malaria control and elimination in China is mainly attributed to governmental leadership, consistent efforts, technological innovations, and adaptive approaches. We also raised that vigilance should focus on imported cases through strengthening surveillance and response systems in order to prevent any re-establishment of transmission after elimination. China should continue to maintain its laboratory, clinical and field epidemiology capabilities. Continuous policy and financial support, multi-sectoral cooperation, and innovative strategies and approaches will remain essential. By integrating these, a malaria-free status can become sustainable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.